Mohammad Ebrahimnezhad

Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics

Peyman Tabnak, Aysa Hasanzade Bashkandi, Mohammad Ebrahimnezhad, 2023, Cancer Cell International.

FOXO1, a tiny protein with intricate interactions: Promising therapeutic candidate in lung cancer.

B. Yousefi, M. Majidinia, Peyman Tabnak, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

lncRNAs: New players of cancer drug resistance via targeting ABC transporters.

M. Majidinia, Maede Rezaie, Mohammad Ebrahimnezhad, 2024, IUBMB life.

Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects.

M. Majidinia, Peyman Tabnak, Mohammad Ebrahimnezhad, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.